BD

Bhishmadeb Dutta

Director Director DIN 02347432
DIN 02347432 First appointment Jan 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2009
Shareholding value •••• Premium profile

About Bhishmadeb Dutta

Data last updated:

Bhishmadeb Dutta was a Director at B D Pharmaceuticals Private Limited (2009–2022) and Director at B D Pharmaceutical Works Private Limited (2009–2022). The companies operate in Pharma.

DIN 02347432
Primary Designation Director
Industry Pharma
First Appointment 27 Jan 2009

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
B D Pharmaceuticals Private Limited U24233WB2009PTC132243
Director27 Jan 20092009₹35.4 Lakh (FY 2024)Active
Director19 Mar 20092009₹14.82 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
B D Pharmaceuticals Private Limited
B D Pharmaceutical Works Private Limited
Premium access

Shareholding and investment profile for Bhishmadeb Dutta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhishmadeb Dutta

Bhishmadeb Dutta was first appointed on 27 Jan 2009 as Director at B D Pharmaceuticals Private Limited.

Bhishmadeb Dutta held 2 earlier board appointments: B D Pharmaceuticals Private Limited (Director, 27 Jan 2009 to 08 Sep 2022); B D Pharmaceutical Works Private Limited (Director, 19 Mar 2009 to 08 Sep 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available